메뉴 건너뛰기




Volumn 11, Issue 7, 2004, Pages 24-

Add-on sibutramine for olanzapine-induced weight gain

(1)  Ginsberg, David L a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CLOZAPINE; DOPAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METFORMIN; NEUROLEPTIC AGENT; NIZATIDINE; NORADRENALIN; OLANZAPINE; ORAL ANTIDIABETIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN; SIBUTRAMINE; TOPIRAMATE;

EID: 3442876113     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (9)
  • 1
    • 0034088152 scopus 로고    scopus 로고
    • Clozapine weight gain, plus topiramate weight loss
    • Dursun SM, Devarajan S. Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry. 2000;45(2):198.
    • (2000) Can J Psychiatry , vol.45 , Issue.2 , pp. 198
    • Dursun, S.M.1    Devarajan, S.2
  • 2
    • 0036221125 scopus 로고    scopus 로고
    • Metformin for weight loss in pediatric patients taking psychotropic drugs
    • Morrison JA, Cottingham EM, Barton BA. Metformin for weight loss in pediatric patients taking psychotropic drugs. Am J Psychiatry. 2002;159(4):655-657.
    • (2002) Am J Psychiatry , vol.159 , Issue.4 , pp. 655-657
    • Morrison, J.A.1    Cottingham, E.M.2    Barton, B.A.3
  • 3
    • 0034661194 scopus 로고    scopus 로고
    • H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients
    • Sacchetti E, Guarneri L, Bravi D. H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biol Psychiatry. 2000;48(2):167-168.
    • (2000) Biol Psychiatry , vol.48 , Issue.2 , pp. 167-168
    • Sacchetti, E.1    Guarneri, L.2    Bravi, D.3
  • 4
    • 0002152513 scopus 로고    scopus 로고
    • Atypical antipsychotic agents and diabetes mellitus
    • Goldstein LE, Henderson DC. Atypical antipsychotic agents and diabetes mellitus. Primary Psychiatry. 2000;7(5):65-68.
    • (2000) Primary Psychiatry , vol.7 , Issue.5 , pp. 65-68
    • Goldstein, L.E.1    Henderson, D.C.2
  • 5
    • 0032852016 scopus 로고    scopus 로고
    • Sibutramine: A serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity
    • Luque CA, Rey JA. Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother. 1999;33(9):968-978.
    • (1999) Ann Pharmacother , vol.33 , Issue.9 , pp. 968-978
    • Luque, C.A.1    Rey, J.A.2
  • 6
    • 0033663511 scopus 로고    scopus 로고
    • Sibutramine-associated psychotic episode
    • Taflinski T, Chojnacka J. Sibutramine-associated psychotic episode. Am J Psychiatry. 2000;157(12):2057-2058.
    • (2000) Am J Psychiatry , vol.157 , Issue.12 , pp. 2057-2058
    • Taflinski, T.1    Chojnacka, J.2
  • 7
    • 0036180464 scopus 로고    scopus 로고
    • Organic hypomania secondary to sibutramine-citalopram interaction
    • Benazzi F. Organic hypomania secondary to sibutramine-citalopram interaction. J Clin Psychiatry. 2002;63(2):165.
    • (2002) J Clin Psychiatry , vol.63 , Issue.2 , pp. 165
    • Benazzi, F.1
  • 8
    • 0036789216 scopus 로고    scopus 로고
    • Sibutramine and panic attacks
    • Binkley K, Knowles SR. Sibutramine and panic attacks. Am J Psychiatry. 2002;159(10):1793-1794.
    • (2002) Am J Psychiatry , vol.159 , Issue.10 , pp. 1793-1794
    • Binkley, K.1    Knowles, S.R.2
  • 9
    • 85011481993 scopus 로고    scopus 로고
    • A placebo-controlled trial of sibutramine added to patients with olanzapine-induced weight gain
    • Henderson DC, Daley TB, Louie P, et al. A placebo-controlled trial of sibutramine added to patients with olanzapine-induced weight gain. World J Biol Psychiatry. 2004;5(suppl 1):164.
    • (2004) World J Biol Psychiatry , vol.5 , Issue.SUPPL. 1 , pp. 164
    • Henderson, D.C.1    Daley, T.B.2    Louie, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.